Connect With PTS

PreVantage: Solutions for Outcome-Based Healthcare

Healthcare’s standard “fee-for-service” model provides compensation based on the quantity and complexity of services provided. However, rising medical costs and the intricacies of healthcare delivery has caused the industry to think outside of the box.

Enter value-based payment models.

The Medicare Access and CHIP Reauthorization Act (MACRA) rewards providers based upon the value of services provided instead of the volume. In laymen’s terms, healthcare systems are now being heavily rewarded (or penalized!) for the efficiency of care – think measurable and positive patient outcomes – instead of the number of tests and treatments provided.

As of January 2019, the payment bonus or penalty has increased to +/- seven percent and the stakes are set to intensify even more next year when the penalty or incentive jumps to nine percent. With so much on the line, it’s essential that healthcare organizations transition smoothly into the world of value-based care.

Our existing suite of point-of-care products is uniquely positioned to meet the needs of this new age healthcare model. Fingerstick testing eliminates the need for cumbersome laboratory analysis and can provide results in minutes instead of days. These quick results may help physicians to accomplish more with each patient visit. Moreover, the risk of a patient’s health worsening between testing and results is potentially decreased.

We recently made the organizational decision to prioritize solutions that help healthcare providers to succeed in this world of value-based payment models. Consequently, the PreVantage brand was born.

PreVantage is a suite of products, strategies, and partnerships created to improve patient and provider satisfaction, increase efficiency, lower costs, and maximize reimbursements while helping healthcare providers inspire patients to live healthier, happier lives.

Simply put, it’s a customized, subscription-based solution that assists the healthcare industry with maximizing reimbursement.

Extensive research and firsthand conversations with healthcare thought leaders have led to nuanced collaborations with Rimidi and eTrueNorth, the first of numerous PreVantage partnerships.

Powered by Rimidi, PreVantage ConnectedCareTM allows for enhanced patient monitoring and coaching through the use of unique digital dashboards for both patients and providers. Unlike many other freestanding chronic disease management platforms, it works seamlessly into the physician or care team’s workflow, integrating directly with providers’ Electronic Health Records.

Powered by eTrueNorth, PreVantage ConnectedQCTM assists users of PTS Diagnostics’ solutions in managing their quality control requirements in a manner consistent with regulatory standards. PreVantage customers are also granted preferred access to eTrueNorth’s eQC suite of policy and procedure and regulatory requirement management programs.

The launch of PreVantage has just begun and we’re excited to shift from strictly a product-based company into a solutions provider that is uniquely positioned within the value-based payment environment!

Are you interested in learning more about how the PreVantage suite of solutions helps to eliminate gaps in care? Connect with a PTS Diagnostics sales rep today and follow us on LinkedIn for periodic updates regarding PreVantage and merit-based incentivization.

Stephen Riendeau | Chief Commercial Officer

Mr. Riendeau joined the PTS Diagnostics in 2007 after 17 years of industry-wide sales experience with Specialty Laboratories, Inc., Myriad Genetic Laboratories, Orca Medical Systems, and Abbott Laboratories, Inc. His professional experience prior to PTS Diagnostics included the servicing of individual accounts, territory management, field sales management, and executive direction of corporate accounts. He has overall responsibility for PTS Diagnostics’ global sales in all healthcare segments, sales distribution, and the development and execution of the company’s strategic sales plan. Mr. Riendeau received a Bachelor of Arts in Economics from Florida State University.

Diabetes Stories From PTS Diagnostics

November is Diabetes Awareness Month. Per the American Diabetes Association, 371 million people worldwide are living with diabetes and this number will balloon to 642 million by 2020 if changes toward prevention are not made globally.  

We spoke with a few members of our PTS Diagnostics family and asked them to share how they’re personally impacted by diabetes and whether this led them to seek professions in the point-of-care industry. Here’s what they said:

Ashley Voils, Document Control Manager

I was only six years old when I received my Type 1 diabetes diagnosis, so I don’t remember much. My mom worked in the medical field and was able to quickly recognize that I was displaying some of the symptoms of Type 1 diabetes; for me these were pounding headaches and a thirst that I couldn’t quench.

Above everything else, I vividly remember the immense feeling of fright that came over me upon   receiving the news. When you’re six you don’t know what diabetes is – What’s happening? What does this mean? Will I have to go to the hospital; or worse?

Luckily, my mom and our doctor were able to explain that diabetes simply meant that my body was having trouble turning sugar from food into energy and that I’d (pretty much J) be able to be just like any other kid, as long as followed my treatment plan and took the necessary medications. As an adult, my greatest accomplishment as a diabetic was giving birth to a healthy baby girl two years ago with few complications.

Growing up as a diabetic has definitely had some level of influence on both my career choice and charitable pursuits. It’s provided tremendous value to my everyday work knowing that I’m making a difference for people of all ages with diabetes. I’m privileged to have been at PTS Diagnostics for 10 years to witness the positive impact that our point-of-care solutions have had on impacted populations.

Scott Lee, Graphic Designer

Type 2 diabetes runs in my family. My father had it, his mother had it, and two of my siblings also have it. I’ve always been predisposed to it and very aware of its lifechanging impact.

The tipping point for me was working in a job with a total commute of 3+ hours. This eventually led to a more sedentary lifestyle than I’d have preferred, and in result, a Type 2 diabetes diagnosis.

The major impact for me has been going from seeing my doctor for checkups to frequent visits for the purpose of diabetes management. I’m also more aware of maintaining a proper diet, specifically focusing on limiting my intake of carbs since I know that this is a key to my insulin balance. What has really stuck with me is that no matter how well I control A1C and other biometric markers, I’ll always be medically categorized as a person with diabetes due to the original diagnosis.

Passion for my work at PTS Diagnostics comes in the form of a “noble why.” I feel a sense of tremendous pride when I create materials that help others with this disease state. This is my way of giving back to the diabetes community and assisting others impacted by all forms of diabetes and their comorbidities. 

Heather Williams, Human Resources

My mom is 59 years old and has battled Type 1 diabetes since age four. Over the years she has been a part of many different studies to help with diabetes management as well as working toward a cure. This is one of the underlying factors in our family’s involvement in diabetes research and related charity work.

I am the oldest of three siblings, a miracle because according to her doctor at the time, I should not have been conceived. I was born a month early and had drastically low blood sugar levels, that resulted in the first few weeks of my life in the NICU.

Growing up, I learned very quickly how to detect when my mom was experiencing drastic changes in her blood sugar and what to do to get her blood sugar back to a normal level, help her with daily insulin shot regimes when my dad was at work, and later helping her with insulin pump placement.

During the pregnancy of my two boys I was closely monitored due to family history for gestational diabetes, which I ended up having during my pregnancy with Nolan, my youngest son. Even though I have a pretty healthy active lifestyle, it was determined that genetics was a factor in my gestational diabetes.

It is amazing to see the evolution in technology for diabetes management and care and how it affects lives from a personal and professional standpoint. Recruiting talented individuals at PTS Diagnostics has been personally satisfying and a great opportunity to help provide means for doctors and clinicians to help individuals with the diagnosis and management of diabetes.

In summary, diabetes management and prevention is a cause that’s near and dear to the entire PTS Diagnostics family. Throughout #DiabetesAwarenessMonth we’ll be giving back to diabetes-related charitable causes through events such as a blue jeans week, low sugar bake-off, and a Thanksgiving pitch-in. Follow the fun and converse with us via our LinkedIn, Facebook, Instagram, and Twitter channels.

Progress Continues on New PTS Diagnostics Global Headquarters

PTS Diagnostics recently broke ground on a state-of-the-art global headquarters in Whitestown, Indiana. As we continue to grow at a rapid pace, this new facility is being added to accommodate the need for additional manufacturing and office space. 

As a Senior Designer, it’s my role to help layout the core laboratory and production zones of the new building so that we can continue to produce and expand the reach of our point-of-care solutions. I’ve been with PTS Diagnostics for 12 years and can honestly say that I’ve never seen such a level of excitement as it pertains to both our internal growth and the global impact of our technology.

The new global headquarters is progressing nicely and we remain on track for a late spring 2019 move-in date. Currently, the building’s first walls are being put up and the next step will be to begin work on roofing and laying concrete for the second floor. Once finished, notable amenities will include creative brainstorming rooms, a workout facility, innovative workspaces, expanded breakroom facilities, ample parking, and an outdoor walking trail and basketball court.

Individuals interested in tracking the construction progress are invited to follow the PTS Diagnostics “Grow With PTS” Facebook album, which will be updated on a monthly basis and more frequently as our move-in date approaches.

Our new global headquarters represents a continued commitment to our employees and our goal of advancing point-of-care technology to improve global outcomes. I believe that I speak for everyone involved with this project when I say that we could not be more excited about the future of PTS Diagnostics.

Tom Harris | Senior Designer

PTS Diagnostics Takes Center Stage at AADE 2018

We’re thrilled to have recently attended the American Association of Diabetes Educator’s annual conference in Baltimore.

AADE 2018 is the United States’ premier diabetes event targeted to health educators and healthcare professionals, i.e., nurses, pharmacists, dietitians, exercise specialists, etc. The conference focuses on continuing diabetes education credit opportunities while intertwining expert research presentations sharing the latest technological advancements and emerging diabetes treatment trends.

One takeaway from the gathering was that diabetes educators’ roles are expanding into multiple phases of treatment and prevention. From diagnosis to education, emotional support, nutrition, exercise and more, the role of an educator is a crucial, yet often overlooked aspect of diabetes management.

A large emphasis that came from the session was a focus on driving better outcomes for people with diabetes by embracing education as a front-line treatment option. Additionally, a shift is occurring among diabetes educators in that there is an increased focus on helping to self-educate individuals living with diabetes and cardiovascular issues, a push driven by the value-based care model. This indicates that there is an expanding need for point-of-care solutions that can support self-management programs and incentives.

On the show floor, PTS Diagnostics conducted hundreds of point-of-care product demonstrations at our booth showcasing our A1CNow®+ and CardioChek® Plus systems. With results in five minutes, the A1CNow system offers healthcare providers a fast and easy way of obtaining accurate HbA1c results via fingerstick. Likewise, the CardioChek Plus accurately tests a full lipid panel and glucose simultaneously in 90 seconds via fingerstick.

The speed at which these measurements are delivered allows for the majority of the time spent during a physician visit to be spent having meaningful diabetes and cardiovascular care conversations with patients. What we learned from the healthcare professionals who stopped by our booth is that they are seeking opportunities for face-to-face “coachable moments” with patients as it’s an important, yet often overlooked, step in the disease management and education process.

Overall, we were ecstatic to have experienced another AADE annual conference and are already counting down the days until next year’s event in Houston! 

Kelley McClain | Manager, Marketing Communications

Impacting Underserved Populations at the Point of Care

In today’s hustle and bustle society, it’s easy to become so encapsulated in day-to-day life that we fail to think globally. I’m fortunate that my role at PTS Diagnostics allows me to escape my personal ‘bubble’ and experience firsthand the global impact that our point-of-care technology makes.

One such unforgettable experience occurred in the remote town of Santo Amaro do Maranhão in northern Brazil. The town is home to about 4,000 residents, many of whom don’t have regular access to healthcare and may drive 5+ hours to the city of São Luís just to obtain it. Needless to say, time and money prevent many from making the trip unless it’s imperative.

Through a partnership with our regional distributor, NL Diagnostica, we worked with the town’s mayor and members of the local government to organize a health event using our A1CNow®+ system. These are fantastic analyzers for such events because they provide accurate HbA1c results in minutes with just a simple fingerstick.

It was an enormous success. We tested 115 residents between the ages of 7 – 87 and identified numerous individuals who were unaware that their results fell into prediabetic and diabetic ranges. They were then directed to physicians who can help to develop and implement personalized treatment plans, potentially altering the course of these individuals’ lives.

Similarly, another recent health event in Mato Grosso, Brazil used our analyzers to test 160 individuals and identified 43 of these individuals whose results fell in ranges that may signify prediabetes or diabetes.

The importance of programs like this cannot be understated. Diabetes, heart disease, and their associated comorbidities are an international epidemic. According to the World Health Organization, the global prevalence of diabetes among adults has risen from 4.7 percent in 1980 to 8.5 percent in 2014 and it rises at a much higher rate in middle and low-income countries. Grassroots initiatives such as the events in Santo Amaro do Maranhão and Mato Grosso help to reach the underserved communities that need point-of-care testing and healthcare support the most.

PTS Diagnostics is currently represented in 135 countries and we’re increasing our commitment to international events in 2018. Other global health events on the calendar for the remainder of the year include locations in South America, Europe, and numerous global trade shows and industry meetings.

Interested in learning more about the global impact of our point-of-care analyzers connect with a PTS Diagnostics sales rep and follow us on LinkedIn, Twitter, and Facebook for periodic updates. 

David Brandt | Senior Director, International Distribution